Disc Medicine IncNASDAQ:IRON
- LAST PRICE64.9600
- TODAY'S CHANGE (%)1.4550 (2.2912%)
- Bid / Lots26.0200/ 2
- Ask / Lots70.2900/ 1
- Open / Previous Close63.3400 / 63.5050
- Day Range
- 52 Week Range
- Volume282,399
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | IRON |
|---|---|---|
| 09:32 ET | 3674 | 63.275 |
| 09:33 ET | 4300 | 63.275 |
| 09:39 ET | 100 | 62.61 |
| 09:50 ET | 1918 | 63.64 |
| 09:53 ET | 2023 | 64.145 |
| 09:55 ET | 2700 | 64.71 |
| 09:57 ET | 1596 | 64.84 |
| 10:00 ET | 800 | 64.255 |
| 10:02 ET | 300 | 64.415 |
| 10:04 ET | 300 | 63.72 |
| 10:09 ET | 300 | 64.71 |
| 10:11 ET | 300 | 64.765 |
| 10:13 ET | 400 | 64.54 |
| 10:15 ET | 100 | 64.38 |
| 10:18 ET | 200 | 64.8 |
| 10:22 ET | 529 | 64.805 |
| 10:24 ET | 400 | 64.57 |
| 10:26 ET | 300 | 64.7 |
| 10:29 ET | 400 | 64.475 |
| 10:31 ET | 100 | 64.2 |
| 10:33 ET | 700 | 64.05 |
| 10:36 ET | 100 | 64.345 |
| 10:38 ET | 200 | 64.67 |
| 10:40 ET | 500 | 64.66 |
| 10:44 ET | 200 | 64.94 |
| 10:45 ET | 200 | 64.65 |
| 10:47 ET | 200 | 64.86 |
| 10:49 ET | 400 | 64.715 |
| 10:54 ET | 589 | 64.655 |
| 10:56 ET | 100 | 64.655 |
| 10:58 ET | 200 | 64.85 |
| 11:00 ET | 200 | 65 |
| 11:02 ET | 267 | 64.85 |
| 11:03 ET | 400 | 64.57 |
| 11:07 ET | 200 | 64.68 |
| 11:09 ET | 300 | 64.46 |
| 11:14 ET | 100 | 64.72 |
| 11:18 ET | 200 | 64.75 |
| 11:20 ET | 200 | 64.76 |
| 11:21 ET | 400 | 64.54 |
| 11:23 ET | 300 | 64.68 |
| 11:27 ET | 800 | 64.575 |
| 11:30 ET | 400 | 64.71 |
| 11:34 ET | 300 | 65 |
| 11:36 ET | 400 | 64.64 |
| 11:39 ET | 200 | 64.76 |
| 11:41 ET | 100 | 64.73 |
| 11:43 ET | 759 | 64.66 |
| 11:45 ET | 200 | 64.64 |
| 11:48 ET | 220 | 64.745 |
| 11:50 ET | 500 | 64.79 |
| 11:54 ET | 700 | 64.72 |
| 11:57 ET | 300 | 64.86 |
| 11:59 ET | 200 | 64.86 |
| 12:01 ET | 200 | 64.58 |
| 12:06 ET | 300 | 64.72 |
| 12:08 ET | 100 | 64.8 |
| 12:10 ET | 500 | 64.705 |
| 12:14 ET | 376 | 64.78 |
| 12:17 ET | 300 | 64.725 |
| 12:19 ET | 200 | 65 |
| 12:21 ET | 736 | 64.75 |
| 12:24 ET | 200 | 64.91 |
| 12:26 ET | 100 | 64.855 |
| 12:30 ET | 300 | 64.74 |
| 12:32 ET | 400 | 64.83 |
| 12:35 ET | 300 | 64.77 |
| 12:39 ET | 100 | 64.84 |
| 12:44 ET | 200 | 64.83 |
| 12:50 ET | 200 | 64.805 |
| 12:51 ET | 3000 | 64.98 |
| 12:55 ET | 300 | 64.98 |
| 01:00 ET | 200 | 64.98 |
| 01:02 ET | 300 | 64.78 |
| 01:04 ET | 200 | 64.86 |
| 01:06 ET | 100 | 64.88 |
| 01:09 ET | 300 | 64.85 |
| 01:11 ET | 320 | 65.13 |
| 01:15 ET | 200 | 64.93 |
| 01:18 ET | 100 | 64.97 |
| 01:20 ET | 200 | 64.97 |
| 01:24 ET | 600 | 64.785 |
| 01:27 ET | 200 | 64.92 |
| 01:29 ET | 300 | 64.95 |
| 01:31 ET | 1800 | 65 |
| 01:33 ET | 301 | 64.83 |
| 01:36 ET | 200 | 64.99 |
| 01:38 ET | 1434 | 65.18 |
| 01:40 ET | 100 | 65.14 |
| 01:42 ET | 333 | 65.01 |
| 01:44 ET | 700 | 64.94 |
| 01:45 ET | 300 | 65.1 |
| 01:47 ET | 400 | 64.99 |
| 01:49 ET | 200 | 65.12 |
| 01:51 ET | 750 | 64.84 |
| 01:56 ET | 200 | 65.03 |
| 01:58 ET | 100 | 65.19 |
| 02:00 ET | 100 | 65.01 |
| 02:05 ET | 100 | 65.13 |
| 02:07 ET | 300 | 65.01 |
| 02:09 ET | 200 | 65.105 |
| 02:12 ET | 426 | 65.17 |
| 02:14 ET | 1135 | 65.26 |
| 02:18 ET | 200 | 65.41 |
| 02:21 ET | 100 | 65.45 |
| 02:23 ET | 200 | 65.38 |
| 02:25 ET | 800 | 65.12 |
| 02:30 ET | 300 | 65.07 |
| 02:34 ET | 100 | 65.21 |
| 02:36 ET | 100 | 65.24 |
| 02:38 ET | 200 | 65.23 |
| 02:39 ET | 1578 | 65.395 |
| 02:41 ET | 100 | 65.34 |
| 02:43 ET | 785 | 65.45 |
| 02:45 ET | 615 | 65.5 |
| 02:48 ET | 409 | 65.5 |
| 02:50 ET | 31829 | 65.535 |
| 02:52 ET | 1200 | 65.61 |
| 02:54 ET | 200 | 65.545 |
| 02:56 ET | 200 | 65.72 |
| 02:57 ET | 400 | 65.44 |
| 02:59 ET | 840 | 65.31 |
| 03:01 ET | 5600 | 65.04 |
| 03:03 ET | 496 | 64.665 |
| 03:06 ET | 100 | 64.58 |
| 03:08 ET | 674 | 64.77 |
| 03:15 ET | 100 | 64.82 |
| 03:19 ET | 300 | 64.86 |
| 03:24 ET | 600 | 65.03 |
| 03:28 ET | 200 | 64.9 |
| 03:30 ET | 100 | 64.915 |
| 03:39 ET | 100 | 64.935 |
| 03:42 ET | 1000 | 64.978 |
| 03:44 ET | 500 | 64.93 |
| 03:46 ET | 100 | 64.89 |
| 03:48 ET | 3800 | 65.04 |
| 03:50 ET | 29572 | 65.1 |
| 03:51 ET | 2677 | 65.095 |
| 03:53 ET | 20304 | 65.125 |
| 03:55 ET | 6786 | 64.92 |
| 03:57 ET | 1004 | 65.01 |
| 04:00 ET | 30858 | 64.96 |
Nov 13, 2024
Disc Medicine to Participate in Upcoming Investor Conferences, from 8:30AM ET on Wednesday Nov 13, 2024 by Dow Jones
8:30AM ET on Wednesday Nov 13, 2024 by Dow Jones
Nov 12, 2024
Disc Medicine Reports Third Quarter 2024 Financial Results and Provides Business Update, from 8:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
8:00AM ET on Tuesday Nov 12, 2024 by Dow JonesPress Release: Disc Medicine Reports Third Quarter 2024 Financial Results and Provides Business Update, from 8:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
8:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
Nov 8, 2024
Press Release: Disc Medicine Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc., from 8:30AM ET on Friday Nov 08, 2024 by Dow Jones
8:30AM ET on Friday Nov 08, 2024 by Dow JonesDisc Medicine Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc., from 8:30AM ET on Friday Nov 08, 2024 by Dow Jones
8:30AM ET on Friday Nov 08, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Disc Medicine Inc | 1.9B | -16.4x | --- |
NewAmsterdam Pharma Company NV | 1.9B | -9.0x | --- |
Structure Therapeutics Inc | 1.7B | -15.1x | --- |
Celldex Therapeutics Inc | 1.7B | -10.5x | --- |
Tarsus Pharmaceuticals Inc | 1.8B | -12.8x | --- |
CG Oncology Inc | 2.2B | -28.2x | --- |
Company Information
Disc Medicine, Inc. is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. The Company's pipeline includes bitopertin for the treatment of erythropoietic porphyrias (Eps) including erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF), and anemia of chronic kidney disease (CKD), and DISC-3405 (formerly MWTX-003) for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, its preclinical programs also include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Bitopertin is the lead product candidate in the Company's heme biosynthesis modulation portfolio. It is developing DISC-3405, a monoclonal antibody against Transmembrane Serine Protease 6 that it licensed from Mabwell Therapeutics, Inc.
Contact Information
- Headquarters
- 321 Arsenal Street, Suite 101WATERTOWN, MA, United States 02472
- Phone
- 617-674-9274
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board
- Donald Nicholson
- President, Chief Executive Officer, Director
- John Quisel
- Chief Financial Officer, Treasurer
- Jean Franchi
- Chief Operating Officer
- Jonathan Yu
- General Counsel
- Rahul Khara
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.9B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 29.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.71 |
EPS | $-3.97 |
Book Value | $14.17 |
P/E Ratio | -16.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
